A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site

July 24, 2003
100 (16) 9434-9439

Abstract

Previous studies have demonstrated that the specificity of Src homology 2 (SH2) and phosphotyrosine-binding domain interactions are mediated by phosphorylated tyrosines and their neighboring amino acids. Two of the first phosphotyrosine-based binding sites were found on middle T antigen of polyoma virus. Tyr-250 acts as a binding site for ShcA, whereas Tyr-315 forms a binding site for the SH2 domain of the p85 subunit of phosphatidylinositol 3-kinase. However, genetic analysis of a given phosphotyrosine's role in signaling can be complicated when it serves as a binding site for multiple proteins. The situation is particularly difficult when the phosphotyrosine serves as a secondary binding site for a protein with primary binding determinates elsewhere. Mutation of a tyrosine residue to phenylalanine blocks association of all bound proteins. Here we show that the mutation of the amino acids following the phosphorylated tyrosine to alanine can reveal phosphotyrosine function as a secondary binding site, while abrogating the phosphotyrosine motif's role as a primary binding site for SH2 domains. We tested this methodology by using middle T antigen. Our results suggest that Tyr-250 is a secondary binding site for phosphatidylinositol 3-kinase, whereas Tyr-315 is a secondary binding site for a yet-to-be-identified protein, which is critical for transformation.

Continue Reading

Acknowledgments

We thank Drs. Joanne Chan, Ole Gjoerup, Helen McNamee, Romesh Subramanian, and Lei Zhang for critical reading of the manuscript and Meacie Fairfax for the manuscript preparation. This work was supported by National Institutes of Health Grants RO1 CA30002-21 and PO1 CA89021-02 (to T.M.R.) and CA34722 and CA50661 (to B.S.).

Supporting Information

Supporting Text
Supporting Text

References

1
Ichaso, N. & Dilworth, S. M. (2001) Oncogene 20, 7908–7916.
2
Dilworth, S. M. (2002) Nat. Rev. Cancer 2, 951–956.
3
Pallas, D. C., Shahrik, L. K., Martin, B. L., Jaspers, S., Miller, T. B., Brautigan, D. L. & Roberts, T. M. (1990) Cell 60, 167–176.
4
Walter, G., Ruediger, R., Slaughter, C. & Mumby, M. (1990) Proc. Natl. Acad. Sci. USA 87, 2521–2525.
5
Glover, H. R., Brewster, C. E. & Dilworth, S. M. (1999) Oncogene 18, 4364–4370.
6
Courtneidge, S. A. & Smith, A. E. (1983) Nature 303, 435–439.
7
Courtneidge, S. A. & Smith, A. E. (1984) EMBO J. 3, 585–591.
8
Kornbluth, S., Sudol, M. & Hanafusa, H. (1987) Nature 325, 171–173.
9
Kypta, R. M., Hemming, A. & Courtneidge, S. A. (1988) EMBO J. 7, 3837–3844.
10
Cheng, S. H., Harvey, R., Espino, P. C., Semba, K., Yamamoto, T., Toyoshima, K. & Smith, A. E. (1988) EMBO J. 7, 3845–3855.
11
Horak, I. D., Kawakami, T., Gregory, F., Robbins, K. C. & Bolen, J. B. (1989) J. Virol. 63, 2343–2347.
12
Dilworth, S. M., Brewster, C. E., Jones, M. D., Lanfrancone, L., Pelicci, G. & Pelicci, P. G. (1994) Nature 367, 87–90.
13
Campbell, K. S., Ogris, E., Burke, B., Su, W., Auger, K. R., Druker, B. J., Schaffhausen, B. S., Roberts, T. M. & Pallas, D. C. (1994) Proc. Natl. Acad. Sci. USA 91, 6344–6348.
14
Talmage, D. A., Freund, R., Young, A. T., Dahl, J., Dawe, C. J. & Benjamin, T. L. (1989) Cell 59, 55–65.
15
Su, W., Liu, W., Schaffhausen, B. S. & Roberts, T. M. (1995) J. Biol. Chem. 270, 12331–12334.
16
Eckhart, W., Hutchinson, M. A. & Hunter, T. (1979) Cell 18, 925–933.
17
Smith, A. E., Smith, R., Griffin, B. & Fried, M. (1979) Cell 18, 915–924.
18
Schaffhausen, B. S. & Benjamin, T. L. (1979) Cell 18, 935–946.
19
Kaplan, D. R., Whitman, M., Schaffhausen, B., Raptis, L., Garcea, R. L., Pallas, D., Roberts, T. M. & Cantley, L. (1986) Proc. Natl. Acad. Sci. USA 83, 3624–3628.
20
Whitman, M., Kaplan, D. R., Schaffhausen, B., Cantley, L. & Roberts, T. M. (1985) Nature 315, 239–242.
21
Kaplan, D. R., Whitman, M., Schaffhausen, B., Pallas, D. C., White, M., Cantley, L. & Roberts, T. M. (1987) Cell 50, 1021–1029.
22
Courtneidge, S. A. & Heber, A. (1987) Cell 50, 1031–1037.
23
Whitman, M., Downes, C. P., Keeler, M., Keller, T. & Cantley, L. (1988) Nature 332, 644–646.
24
Yoakim, M., Hou, W., Liu, Y., Carpenter, C. L., Kapeller, R. & Schaffhausen, B. S. (1992) J. Virol. 66, 5485–5491.
25
Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., et al. (1993) Cell 72, 767–778.
26
Carmichael, G., Schaffhausen, B. S., Mandel, G., Liang, T. J. & Benjamin, T. L. (1984) Proc. Natl. Acad. Sci. USA 81, 679–683.
27
Markland, W., Oostra, B. A., Harvey, R., Markham, A. F., Colledge, W. H. & Smith, A. E. (1986) J. Virol. 59, 384–391.
28
Oostra, B. A., Harvey, R., Ely, B. K., Markham, A. F. & Smith, A. E. (1983) Nature 304, 456–459.
29
Markland, W. & Smith, A. E. (1987) Biochim. Biophys. Acta 907, 299–321.
30
Ong, S. H., Dilworth, S., Hauck-Schmalenberger, I., Pawson, T. & Kiefer, F. (2001) EMBO J. 20, 6327–6336.
31
Druker, B. J., Ling, L. E., Cohen, B., Roberts, T. M. & Schaffhausen, B. S. (1990) J. Virol. 64, 4454–4461.
32
Druker, B. J., Sibert, L. & Roberts, T. M. (1992) J. Virol. 66, 5770–5776.
33
Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. (1993) Proc. Natl. Acad. Sci. USA 90, 8392–8396.
34
Chen, C. A. & Okayama, H. (1988) BioTechniques 6, 632–638.
35
Cherington, V., Morgan, B., Spiegelman, B. M. & Roberts, T. M. (1986) Proc. Natl. Acad. Sci. USA 83, 4307–4311.
36
Pallas, D. C., Schley, C., Mahoney, M., Harlow, E., Schaffhausen, B. S. & Roberts, T. M. (1986) J. Virol. 60, 1075–1084.
37
Auger, K. R., Wang, J., Narsimhan, R. P., Holcombe, T. & Roberts, T. M. (2000) Biochem. Biophys. Res. Commun. 272, 822–829.
38
Kashishian, A., Kazlauskas, A. & Cooper, J. A. (1992) EMBO J. 11, 1373–1382.
39
Smart, J. E., Oppermann, H., Czernilofsky, A. P., Purchio, A. F., Erikson, R. L. & Bishop, J. M. (1981) Proc. Natl. Acad. Sci. USA 78, 6013–6017.
40
Patschinsky, T., Hunter, T., Esch, F. S., Cooper, J. A. & Sefton, B. M. (1982) Proc. Natl. Acad. Sci. USA 79, 973–977.
41
Nishimura, R., Li, W., Kashishian, A., Mondino, A., Zhou, M., Cooper, J. & Schlessinger, J. (1993) Mol. Cell. Biol. 13, 6889–6896.
42
Bradshaw, J. M. & Waksman, G. (1999) Biochemistry 38, 5147–5154.
43
Xu, W., Harrison, S. C. & Eck, M. J. (1997) Nature 385, 595–602.
44
DeMali, K. A., Whiteford, C. C., Ulug, E. T. & Kazlauskas, A. (1997) J. Biol. Chem. 272, 9011–9018.

Information & Authors

Information

Published in

The cover image for PNAS Vol.100; No.16
Proceedings of the National Academy of Sciences
Vol. 100 | No. 16
August 5, 2003
PubMed: 12881485

Classifications

Submission history

Received: January 29, 2003
Published online: July 24, 2003
Published in issue: August 5, 2003

Acknowledgments

We thank Drs. Joanne Chan, Ole Gjoerup, Helen McNamee, Romesh Subramanian, and Lei Zhang for critical reading of the manuscript and Meacie Fairfax for the manuscript preparation. This work was supported by National Institutes of Health Grants RO1 CA30002-21 and PO1 CA89021-02 (to T.M.R.) and CA34722 and CA50661 (to B.S.).

Authors

Affiliations

Y. Kate Hong
Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115; and Department of Biochemistry, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111
Aki Mikami
Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115; and Department of Biochemistry, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111
Brian Schaffhausen
Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115; and Department of Biochemistry, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111
Toni Jun
Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115; and Department of Biochemistry, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111
Thomas M. Roberts,**
Department of Cancer Biology, Dana–Farber Cancer Institute, and Department of Pathology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115; and Department of Biochemistry, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111

Notes

To whom correspondence should be addressed. E-mail: [email protected].
Y.K.H. and A.M. contributed equally to this work.
Present address: Amgen Cambridge Research Center, Building 1000, One Kendall Square, Cambridge, MA 02139.
**
In compliance with Harvard Medical School guidelines on possible conflict of interest, we disclose that T.M.R. has consulting relationships with Upstate Biotechnology and Novartis Pharmaceuticals.
Communicated by David M. Livingston, Dana–Farber Cancer Institute, Boston, MA, May 16, 2003

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Altmetrics

Citations

Export the article citation data by selecting a format from the list below and clicking Export.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site
    Proceedings of the National Academy of Sciences
    • Vol. 100
    • No. 16
    • pp. 9103-9636

    Figures

    Tables

    Media

    Share

    Share

    Share article link

    Share on social media